Cargando…

Leucine‐enriched whey protein supplementation, resistance‐based exercise, and cardiometabolic health in older adults: a randomized controlled trial

BACKGROUND: Increasing protein intake (above the Recommended Dietary Amount) alone or with resistance‐based exercise is suggested to improve cardiometabolic health; however, randomized controlled trials (RCTs) are needed to confirm this. METHODS: The Liverpool Hope University‐Sarcopenia Aging Trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirk, Ben, Mooney, Kate, Vogrin, Sara, Jackson, Matthew, Duque, Gustavo, Khaiyat, Omid, Amirabdollahian, Farzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718053/
https://www.ncbi.nlm.nih.gov/pubmed/34520104
http://dx.doi.org/10.1002/jcsm.12805
_version_ 1784624640223608832
author Kirk, Ben
Mooney, Kate
Vogrin, Sara
Jackson, Matthew
Duque, Gustavo
Khaiyat, Omid
Amirabdollahian, Farzad
author_facet Kirk, Ben
Mooney, Kate
Vogrin, Sara
Jackson, Matthew
Duque, Gustavo
Khaiyat, Omid
Amirabdollahian, Farzad
author_sort Kirk, Ben
collection PubMed
description BACKGROUND: Increasing protein intake (above the Recommended Dietary Amount) alone or with resistance‐based exercise is suggested to improve cardiometabolic health; however, randomized controlled trials (RCTs) are needed to confirm this. METHODS: The Liverpool Hope University‐Sarcopenia Aging Trial (LHU‐SAT) was a 16 week RCT (ClinicalTrials.gov Identifier: NCT02912130) of 100 community‐dwelling older adults [mean age: 68.73 ± 5.80 years, body mass index: 27.06 ± 5.18 kg/m(2) (52% women)] who were randomized to four independent groups [Control (C), Exercise (E), Exercise + Protein (EP), Protein (P)]. E and EP completed supervised and progressive resistance‐based exercise (resistance exercise: two times per week, functional circuit exercise: once per week), while EP and P were supplemented with a leucine‐enriched whey protein drink (three times per day) based on individual body weight (0.50 g/kg/meal, 1.50 g/kg/day). Outcome measures including arterial stiffness (pulse wave velocity), fasting plasma/serum biomarkers [glucose/glycated haemoglobin, total cholesterol, low‐density lipoprotein (LDL), high‐density lipoprotein, insulin, resistin, leptin, adiponectin, C‐reactive protein, tumour necrosis factor‐alpha, interleukin‐6, cystatin‐C, & ferritin], insulin resistance (HOMA‐IR), and kidney function (eGFR) were measured before and after intervention. RESULTS: Total protein intake (habitual diet plus supplementation) increased to 1.55 ± 0.69 g/kg/day in EP and to 1.93 ± 0.72 g/kg/day in P, and remained significantly lower (P < 0.001) in unsupplemented groups (E: 1.08 ± 0.33 g/kg/day, C: 1.00 ± 0.26 g/kg/day). At 16 weeks, there was a group‐by‐time interaction whereby absolute changes in LDL‐cholesterol were lower in EP [mean difference: −0.79 mmol/L, 95% confidence interval (CI): −1.29, −0.28, P = 0.002] and P (mean difference: −0.76 mmol/L, 95% CI: −1.26, −0.26, P = 0.003) vs. C. Serum insulin also showed group‐by‐time interactions at 16 weeks whereby fold changes were lower in EP (mean difference: −0.40, 95% CI: −0.65, −0.16, P = 0.001) and P (mean difference: −0.32, 95% CI: −0.56, −0.08, P = 0.009) vs. C, and fold changes in HOMA‐IR improved in EP (mean difference: −0.37, 95% CI: −0.64, −0.10, P = 0.007) and P (mean difference: −0.27, 95% CI: −0.53, −0.00, P = 0.048) vs. C. Serum resistin declined in P only (group‐by‐time interaction at 16 weeks: P = 0.009). No other interactions were observed in outcome measures (P > 0.05), and kidney function (eGFR) remained unaltered. CONCLUSIONS: Sixteen weeks of leucine‐enriched whey protein supplementation alone and combined with resistance‐based exercise improved cardiometabolic health markers in older adults.
format Online
Article
Text
id pubmed-8718053
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87180532022-01-06 Leucine‐enriched whey protein supplementation, resistance‐based exercise, and cardiometabolic health in older adults: a randomized controlled trial Kirk, Ben Mooney, Kate Vogrin, Sara Jackson, Matthew Duque, Gustavo Khaiyat, Omid Amirabdollahian, Farzad J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: Increasing protein intake (above the Recommended Dietary Amount) alone or with resistance‐based exercise is suggested to improve cardiometabolic health; however, randomized controlled trials (RCTs) are needed to confirm this. METHODS: The Liverpool Hope University‐Sarcopenia Aging Trial (LHU‐SAT) was a 16 week RCT (ClinicalTrials.gov Identifier: NCT02912130) of 100 community‐dwelling older adults [mean age: 68.73 ± 5.80 years, body mass index: 27.06 ± 5.18 kg/m(2) (52% women)] who were randomized to four independent groups [Control (C), Exercise (E), Exercise + Protein (EP), Protein (P)]. E and EP completed supervised and progressive resistance‐based exercise (resistance exercise: two times per week, functional circuit exercise: once per week), while EP and P were supplemented with a leucine‐enriched whey protein drink (three times per day) based on individual body weight (0.50 g/kg/meal, 1.50 g/kg/day). Outcome measures including arterial stiffness (pulse wave velocity), fasting plasma/serum biomarkers [glucose/glycated haemoglobin, total cholesterol, low‐density lipoprotein (LDL), high‐density lipoprotein, insulin, resistin, leptin, adiponectin, C‐reactive protein, tumour necrosis factor‐alpha, interleukin‐6, cystatin‐C, & ferritin], insulin resistance (HOMA‐IR), and kidney function (eGFR) were measured before and after intervention. RESULTS: Total protein intake (habitual diet plus supplementation) increased to 1.55 ± 0.69 g/kg/day in EP and to 1.93 ± 0.72 g/kg/day in P, and remained significantly lower (P < 0.001) in unsupplemented groups (E: 1.08 ± 0.33 g/kg/day, C: 1.00 ± 0.26 g/kg/day). At 16 weeks, there was a group‐by‐time interaction whereby absolute changes in LDL‐cholesterol were lower in EP [mean difference: −0.79 mmol/L, 95% confidence interval (CI): −1.29, −0.28, P = 0.002] and P (mean difference: −0.76 mmol/L, 95% CI: −1.26, −0.26, P = 0.003) vs. C. Serum insulin also showed group‐by‐time interactions at 16 weeks whereby fold changes were lower in EP (mean difference: −0.40, 95% CI: −0.65, −0.16, P = 0.001) and P (mean difference: −0.32, 95% CI: −0.56, −0.08, P = 0.009) vs. C, and fold changes in HOMA‐IR improved in EP (mean difference: −0.37, 95% CI: −0.64, −0.10, P = 0.007) and P (mean difference: −0.27, 95% CI: −0.53, −0.00, P = 0.048) vs. C. Serum resistin declined in P only (group‐by‐time interaction at 16 weeks: P = 0.009). No other interactions were observed in outcome measures (P > 0.05), and kidney function (eGFR) remained unaltered. CONCLUSIONS: Sixteen weeks of leucine‐enriched whey protein supplementation alone and combined with resistance‐based exercise improved cardiometabolic health markers in older adults. John Wiley and Sons Inc. 2021-09-14 2021-12 /pmc/articles/PMC8718053/ /pubmed/34520104 http://dx.doi.org/10.1002/jcsm.12805 Text en © 2021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Kirk, Ben
Mooney, Kate
Vogrin, Sara
Jackson, Matthew
Duque, Gustavo
Khaiyat, Omid
Amirabdollahian, Farzad
Leucine‐enriched whey protein supplementation, resistance‐based exercise, and cardiometabolic health in older adults: a randomized controlled trial
title Leucine‐enriched whey protein supplementation, resistance‐based exercise, and cardiometabolic health in older adults: a randomized controlled trial
title_full Leucine‐enriched whey protein supplementation, resistance‐based exercise, and cardiometabolic health in older adults: a randomized controlled trial
title_fullStr Leucine‐enriched whey protein supplementation, resistance‐based exercise, and cardiometabolic health in older adults: a randomized controlled trial
title_full_unstemmed Leucine‐enriched whey protein supplementation, resistance‐based exercise, and cardiometabolic health in older adults: a randomized controlled trial
title_short Leucine‐enriched whey protein supplementation, resistance‐based exercise, and cardiometabolic health in older adults: a randomized controlled trial
title_sort leucine‐enriched whey protein supplementation, resistance‐based exercise, and cardiometabolic health in older adults: a randomized controlled trial
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718053/
https://www.ncbi.nlm.nih.gov/pubmed/34520104
http://dx.doi.org/10.1002/jcsm.12805
work_keys_str_mv AT kirkben leucineenrichedwheyproteinsupplementationresistancebasedexerciseandcardiometabolichealthinolderadultsarandomizedcontrolledtrial
AT mooneykate leucineenrichedwheyproteinsupplementationresistancebasedexerciseandcardiometabolichealthinolderadultsarandomizedcontrolledtrial
AT vogrinsara leucineenrichedwheyproteinsupplementationresistancebasedexerciseandcardiometabolichealthinolderadultsarandomizedcontrolledtrial
AT jacksonmatthew leucineenrichedwheyproteinsupplementationresistancebasedexerciseandcardiometabolichealthinolderadultsarandomizedcontrolledtrial
AT duquegustavo leucineenrichedwheyproteinsupplementationresistancebasedexerciseandcardiometabolichealthinolderadultsarandomizedcontrolledtrial
AT khaiyatomid leucineenrichedwheyproteinsupplementationresistancebasedexerciseandcardiometabolichealthinolderadultsarandomizedcontrolledtrial
AT amirabdollahianfarzad leucineenrichedwheyproteinsupplementationresistancebasedexerciseandcardiometabolichealthinolderadultsarandomizedcontrolledtrial